Efficacy and Safety of TACE Combined with Regorafenib Versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma with Untreatable Progression after TACE Combined with Sorafenib Therapy: A Case Control Study.
CANCER CONTROL（2024）
Key words
hepatocellular carcinoma,transarterial chemoembolization,refractory,regorafenib,camrelizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined